Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: AIDS Behav. 2019 Jan;23(1):105–115. doi: 10.1007/s10461-018-2264-5

Table III.

PrEP access and use by participants in the counseling intervention group compared to the control group assessed at the 3-month follow up visit (n=48).

Variable Intervention Group (n=25) Control Group
(n=23)
n (%) n (%) χ2, p
Has seen a medical provider in the last 3 months 13 (52) 12 (52) <0.1,0.99
Has talked to a medical provider about PrEP in the last 3 months a 11 (85) 5 (42) 0.041*
Has taken PrEP in the last 3 months 6 (24) 0 (0) 0.023*
Currently taking PrEP 4 (16) 0 (0) 0.11*
Plans to continue taking PrEP b 5 (83) NA NA
Plans to begin taking PrEP within the next 3 months c 17 (81) 13 (57) 0.11*
*

These p-values were obtained using Fisher’s exact tests.

a

Among participants who saw a medical provider in the last 3 months.

b

Among participants who have taken PrEP in the last 3 months. The denominator for the control group is 0, so calculation of a frequency and proportion is not applicable for the control group.

c

Among participants who are not currently taking PrEP.